secwatch.observer — SEC 8-K summary
======================================

Issuer:     MYRIAD GENETICS INC (MYGN)
CIK:        0000899923
Form:       8-K
Filed at:   2026-10-09T20:16:05+00:00
Accession:  0000899923-26-000084
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Myriad Genetics pays former CCO Brian Donnelly $1.32M severance; accelerates 2 years of equity vesting
--------------------------------------------------------------------------------

- Brian Donnelly, former Chief Commercial Officer, separated Sept 21, 2026; departure from CCO role effective Sept 16, 2026.
- Lump-sum severance of $1,322,294 equals base salary $576,800, target bonus $432,600, and pro-rata FY2026 bonus $312,894.
- Time-based equity awards scheduled to vest within 2 years of separation accelerate, deemed monthly over 24 months; performance awards remain outstanding up to 2 years.
- COBRA premiums paid up to 1 year or until new employment; agreement dated Oct 6, 2026, effective Oct 14, 2026 after 7-day revocation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/899923/000089992326000084/0000899923-26-000084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/899923/000089992326000084/mygn-20261006.htm
  HTML page:      https://secwatch.observer/filing/0000899923-26-000084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer